Understanding P. falciparum asymptomatic infections: a proposition for a transcriptomic approach per Kimenyi, KM, Wamae, K, Ochola-Oyier, LI

Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018 per Kimenyi, KM, Wamae, K, Ngoi, JM, de Laurent, ZR, Ndwiga, L, Osoti, V, Obiero, G, Abdi, AI, Bejon, P, Ochola-Oyier, LI

Amplicon sequencing as a potential surveillance tool for complexity of infection and drug resistance markers in Plasmodium falciparum asymptomatic infections per Wamae, K, Kimenyi, KM, Osoti, V, de Laurent, ZR, Ndwiga, L, Kharabora, O, Hathaway, NJ, Bailey, JA, Juliano, JJ, Bejon, P, Ochola-Oyier, LI

Distinct transcriptomic signatures define febrile malaria depending on initial infective states, asymptomatic or uninfected per Kimenyi, KM, Akinyi, MY, Mwikali, K, Gilmore, T, Mwangi, S, Omer, E, Gichuki, B, Wambua, J, Njunge, J, Obiero, G, Bejon, P, Langhorne, J, Abdi, A, Ochola-Oyier, LI

Targeted amplicon deep sequencing for monitoring antimalarial resistance markers in western Kenya per Osoti, V, Akinyi, M, Wamae, K, Kimenyi, KM, de Laurent, Z, Ndwiga, L, Gichuki, P, Okoyo, C, Kepha, S, Mwandawiro, C, Kandie, R, Bejon, P, Snow, RW, Ochola-Oyier, LI

A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa per Ndwiga, L, Kimenyi, KM, Wamae, K, Osoti, V, Akinyi, M, Omedo, I, Ishengoma, DS, Duah-Quashie, N, Andagalu, B, Ghansah, A, Amambua-Ngwa, A, Tukwasibwe, S, Tessema, SK, Karema, C, Djimde, AA, Dondorp, AM, Raman, J, Snow, RW, Bejon, P, Ochola-Oyier, LI